J B Chemicals and Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2081.4, up 0.53% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.31% on the day, quoting at 25504.3. The Sensex is at 82333.07, up 0.13%. J B Chemicals & Pharmaceuticals Ltd has added around 10.86% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has added around 5.55% in last one month and is currently quoting at 22632.05, up 1.62% on the day. The volume in the stock stood at 86468 shares today, compared to the daily average of 3.2 lakh shares in last one month.The PE of the stock is 45.69 based on TTM earnings ending December 25.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 2032.7, up 1.62% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.36% on the day, quoting at 25662.7. The Sensex is at 83141.63, up 0.39%. J B Chemicals & Pharmaceuticals Ltd has risen around 8.27% in last one month. Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has risen around 3.27% in last one month and is currently quoting at 22452.4, up 0.21% on the day. The volume in the stock stood at 2.34 lakh shares today, compared to the daily average of 2.97 lakh shares in last one month.The PE of the stock is 44.18 based on TTM earnings ending December 25.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals has allotted 31,160 equity shares under ESOS on 19 February 2026. Consequently, the issued, subscribed and paid-up capital has increased from 16,05,27,546 equity shares of Re. 1 each to 16,05,58,706 equity shares of Re. 1 each. Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 5 February 2026, inter alia, have recommended the interim dividend of Rs 12.7 per equity Share (i.e. 1270%) , subject to the approval of the shareholders.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals announced that interim dividend of Rs 12.70 per equity share of face value of Re 1 for FY 2025-26 will be paid on or after 25 February 2026. Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals has appointed Kaushal Solanki as the Chief Financial Officer of the Company and Key Managerial Personnel with effect from 05 February 2026Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live

eClerx Services Ltd, Bajaj Finserv Ltd, Marico Ltd, Force Motors Ltd are among the other stocks to see a surge in volumes on BSE today, 28 January 2026.J B Chemicals & Pharmaceuticals Ltd recorded volume of 2.11 lakh shares by 10:46 IST on BSE, a 62.37 times surge over two-week average daily volume of 3382 shares. The stock lost 1.29% to Rs.1,857.00. Volumes stood at 2097 shares in the last session.eClerx Services Ltd registered volume of 2.11 lakh shares by 10:46 IST on BSE, a 34.71 fold spurt over two-week average daily volume of 6080 shares. The stock slipped 0.07% to Rs.4,401.80. Volumes stood at 2896 shares in the last session.Bajaj Finserv Ltd notched up volume of 20.44 lakh shares by 10:46 IST on BSE, a 22.17 fold spurt over two-week average daily volume of 92220 shares. The stock rose 0.82% to Rs.1,931.40. Volumes stood at 63797 shares in the last session.Marico Ltd witnessed volume of 4.93 lakh shares by 10:46 IST on BSE, a 15.15 times surge over two-week average daily volume of 32546 shares. The stock dropped 3.03% to Rs.723.30. Volumes stood at 36396 shares in the last session.Force Motors Ltd registered volume of 87933 shares by 10:46 IST on BSE, a 10.69 fold spurt over two-week average daily volume of 8227 shares. The stock rose 0.25% to Rs.18,845.00. Volumes stood at 14290 shares in the last session.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals has allotted 37,84,100 equity shares under ESOS on 21 January 2026. Consequently, the issued, subscribed and paid-up capital has increased from 15,66,50,956 equity shares of Re. 1 each to 16,04,35,056 equity shares of Re. 1 each. Powered by Capital Market - Live

Profit before tax (PBT) stood at Rs 266.87 crore in Q3 FY26, up 22.42% from Rs 217.99 crore reported in the corresponding quarter last year. In Q3 FY26, operating EBITDA stood at Rs 305 crore, up 12.96%, compared with Rs 270 crore posted in the same quarter last year. Operating EBITDA margin stood at 28.7% in Q3 FY26 as against 28.1% in Q3 FY25. Nikhil Chopra, CEO and whole-time director of JB Pharma, stated, 'JB Pharma's domestic formulations business once again outperformed the Indian pharmaceutical market, driven by broad-based momentum across key chronic therapies and continued strength in our flagship brands. On the international front, while the CDMO business continued its positive momentum, the international formulations business also recorded strong growth in several key markets. Our focus on cost optimization, favorable product mix, and operational efficiencies led to improved operating margins for Q3 FY26 as well as for 9M FY26. With a strong balance sheet, net cash position, and sustained cash flow generation, we remain confident in our ability to deliver profitable growth. As we move forward, our priorities remain centered on strengthening flagship brand franchises, accelerating growth in chronic therapies, scaling our CDMO businesses, and building a resilient, agile, and future-ready organization.' JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radiodiagnostics, APIs, and intermediates.Powered by Capital Market - Live